Prosight Management as of June 30, 2025
Portfolio Holdings for Prosight Management
Prosight Management holds 39 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Galapagos Nv Spon Adr (GLPG) | 12.1 | $50M | 1.8M | 27.99 | |
| UnitedHealth (UNH) | 8.4 | $34M | 110k | 311.97 | |
| Meiragtx Holdings (MGTX) | 7.3 | $30M | 4.6M | 6.52 | |
| Adc Therapeutics Sa SHS (ADCT) | 6.8 | $28M | 11M | 2.68 | |
| Bridgebio Pharma (BBIO) | 5.0 | $20M | 473k | 43.18 | |
| Roivant Sciences SHS (ROIV) | 5.0 | $20M | 1.8M | 11.27 | |
| Amicus Therapeutics (FOLD) | 4.9 | $20M | 3.5M | 5.73 | |
| Janux Therapeutics (JANX) | 4.8 | $20M | 854k | 23.10 | |
| Kura Oncology (KURA) | 4.5 | $18M | 3.2M | 5.77 | |
| Zymeworks Del (ZYME) | 4.0 | $16M | 1.3M | 12.55 | |
| Icon SHS (ICLR) | 3.5 | $14M | 99k | 145.45 | |
| Argenx Se Sponsored Adr (ARGX) | 3.0 | $12M | 22k | 551.22 | |
| Mirum Pharmaceuticals (MIRM) | 2.5 | $10M | 200k | 50.89 | |
| Syndax Pharmaceuticals (SNDX) | 2.5 | $10M | 1.1M | 9.37 | |
| Tectonic Therapeutic (TECX) | 2.1 | $8.8M | 442k | 19.87 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.1 | $8.6M | 298k | 28.76 | |
| Cytomx Therapeutics (CTMX) | 1.9 | $8.0M | 3.5M | 2.27 | |
| Immunovant (IMVT) | 1.9 | $7.7M | 479k | 16.00 | |
| Biohaven (BHVN) | 1.9 | $7.6M | 539k | 14.11 | |
| Concentra Group Holdings Par Common Stock (CON) | 1.6 | $6.4M | 312k | 20.57 | |
| Livanova SHS (LIVN) | 1.5 | $6.3M | 140k | 45.02 | |
| Dex (DXCM) | 1.5 | $6.1M | 70k | 87.29 | |
| Caredx (CDNA) | 1.4 | $5.9M | 303k | 19.54 | |
| Select Medical Holdings Corporation (SEM) | 1.3 | $5.4M | 354k | 15.18 | |
| Shattuck Labs (STTK) | 1.3 | $5.3M | 6.6M | 0.79 | |
| Acadia Healthcare (ACHC) | 1.2 | $4.8M | 212k | 22.69 | |
| Corbus Pharmaceuticals Hldgs Com New (CRBP) | 1.0 | $4.0M | 580k | 6.90 | |
| Rocket Pharmaceuticals (RCKT) | 0.9 | $3.9M | 1.6M | 2.45 | |
| Sight Sciences (SGHT) | 0.9 | $3.6M | 872k | 4.13 | |
| Axogen (AXGN) | 0.7 | $3.1M | 283k | 10.85 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.7 | $2.8M | 35k | 81.86 | |
| Mural Oncology Pub Ord Shs (MURA) | 0.5 | $2.2M | 900k | 2.47 | |
| Prothena Corp SHS (PRTA) | 0.4 | $1.6M | 268k | 6.07 | |
| Orthopediatrics Corp. (KIDS) | 0.4 | $1.6M | 74k | 21.48 | |
| Pliant Therapeutics (PLRX) | 0.2 | $971k | 837k | 1.16 | |
| Rein Therapeutics Com New (RNTX) | 0.1 | $599k | 428k | 1.40 | |
| Onkure Therapeutics Com Cl A (OKUR) | 0.1 | $382k | 160k | 2.39 | |
| Erasca (ERAS) | 0.1 | $305k | 240k | 1.27 | |
| Pepgen (PEPG) | 0.1 | $271k | 244k | 1.11 |
